Transcriptome Sequencing Analysis of Peripheral Blood of Type 2 Diabetes Mellitus Patients With Thirst and Fatigue

The purpose of this study is to explore the differences in transcriptome expression profiles between healthy subjects and type 2 diabetes mellitus patients with thirst and fatigue (D-T2DM) and, in addition, to investigate the possible role of noncoding ribonucleic acids (RNAs) in the pathogenesis of...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in endocrinology (Lausanne) Vol. 11; p. 558344
Main Authors Lv, Bohan, Bao, Xueli, Li, Ping, Lian, Juan, Wu, Yanxiang, An, Tian, Zhang, Jing, Yang, Xiuyan, Wang, Tingye, Zhu, Jiajian, Hu, Yuanyuan, Jiang, Guangjian, Gao, Sihua
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 09.11.2020
Subjects
Online AccessGet full text
ISSN1664-2392
1664-2392
DOI10.3389/fendo.2020.558344

Cover

More Information
Summary:The purpose of this study is to explore the differences in transcriptome expression profiles between healthy subjects and type 2 diabetes mellitus patients with thirst and fatigue (D-T2DM) and, in addition, to investigate the possible role of noncoding ribonucleic acids (RNAs) in the pathogenesis of D-T2DM. We constructed the expression profiles of RNAs by RNA sequencing in the peripheral blood of D-T2DM patients and healthy subjects and analyzed differentially expressed RNAs. Compared with healthy subjects, a total of 469 mRNAs, 776 long non-coding RNAs (lncRNAs), and 21 circular RNAs (circRNAs) were differentially expressed in D-T2DM patients. Furthermore, several genes associated with insulin resistance, inflammation, and mitochondrial dysfunction were identified within the differentially expressed mRNAs. Differentially expressed lncRNAs were primarily involved in biological processes associated with immune responses. In addition, differentially expressed circRNAs may target miRNAs associated with glucose metabolism and mitochondrial function. Our results may bring a new perspective on differential RNA expression involved in the pathogenesis of D-T2DM and promote the development of novel treatments for this disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Emily Louise Clark, University of Edinburgh, United Kingdom; Daniela Patrizia Foti, University of Catanzaro, Italy
Edited by: Marcus M. Seldin, University of California, Irvine, United States
These authors have contributed equally to this work
This article was submitted to Systems Endocrinology, a section of the journal Frontiers in Endocrinology
ISSN:1664-2392
1664-2392
DOI:10.3389/fendo.2020.558344